Product Program year 2024 Source: CMS Open Payments

Xact

Device Vascular

PDI 08717648010354

Open in the dashboard

General payments

$193,423

1,109 payments

Research payments

$0

0 payments

Through program year 2024, $193,423 in general payments and $0 in research payments were reported against Xact (Vascular).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2024 General $151,209 705
2023 General $25,786 230
2022 General $16,429 174

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $193,423 1,109 payments
Top recipients General payments · program year 2024
  1. Peter Faries Vascular Surgery · New York, NY $17,780 12% · 21 payments
  2. Malcolm Foster Interventional Cardiology · Knoxville, TN $14,289 9% · 26 payments
  3. Prakash Krishnan Interventional Cardiology · New York, NY $13,300 9% · 2 payments
  4. Peter Schneider Vascular Surgery · Honolulu, HI $9,403 6% · 12 payments
  5. David Metzger Cardiovascular Disease · Kingsport, TN $6,000 4% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Interventional Cardiology Internal Medicine $72,833 48% · 66 practitioners
  2. Vascular Surgery Surgery $34,424 23% · 28 practitioners
  3. Cardiovascular Disease Internal Medicine $23,958 16% · 32 practitioners
  4. Vascular & Interventional Radiology Radiology $6,258 4% · 11 practitioners
  5. Diagnostic Radiology Radiology $2,441 2% · 15 practitioners

The top 5 of 32 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. New York $36,392 24% · 8 recipients
  2. Tennessee $19,372 13% · 12 recipients
  3. Texas $16,569 11% · 42 recipients
  4. Hawaii $9,403 6% · 1 recipient
  5. Ohio $8,683 6% · 13 recipients

The top 5 of 35 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

1,109 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record